Project Grant K23MH138759
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Pittsburgh a $185,552 Project Grant effective September 19, 2025, through August 31, 2030, under the Mental Health Research Grants program (CFDA 93.242). This K23 award funds a research investigation examining neurocognitive responses to social threat and their relationship to social connectedness and suicidality in adolescent girls. The project addresses the rising suicide rates among...
- Federal Grant Award Summary The University of Pittsburgh received a $734,220 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded July 15, 2025, with completion targeted for April 30, 2030. This research initiative examines the neurobiological and behavioral mechanisms linking early life adversity (maltreatment and neighborhood violence exposure) to increased depression risk and treatment resistance in youth. The...
- Federal Grant Award Summary The University of Pittsburgh received a $792,006 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded September 1, 2025, with completion targeted for June 30, 2030. This research initiative addresses suicidality in autistic adults through a longitudinal study enrolling 250 participants (ages 18-40), with at least half representing high-risk individuals with active suicidal ideation...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Pittsburgh a $782,547 Project Grant on August 19, 2025, under the Mental Health Research Grants program (CFDA 93.242) to investigate the neurobiological mechanisms underlying anxiety disorders in adolescents. The research will examine how pubertal development impacts the maturation of corticostriatal circuitry—neural networks implicated in reward processing and learning—and how alterations in...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a $728,751 Project Grant to the University of Pittsburgh under the Mental Health Research Grants program (CFDA 93.242) for the period April 1, 2026 through March 31, 2031. This research project investigates the neural mechanisms underlying antidepressant placebo effects in patients with major depressive disorder (MDD). The study employs theta burst stimulation (TBS) to examine the causal roles of the salience...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded University of Colorado-Denver a Project Grant of $601,576 under the Mental Health Research Grants program (CFDA 93.242) on May 15, 2025, with completion scheduled for May 14, 2028. This three-year R34 developmental grant supports the iterative development and pilot evaluation of SURE-KIDS, the first outpatient, research-supported treatment intervention specifically designed for preadolescents experiencing...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a $1,402,271 Project Grant to The Washington University's Office of Sponsored Research Services on May 1, 2025, with a completion date of February 28, 2029, under the Mental Health Research Grants program (CFDA 93.242). This research project, titled "Predicting Attenuated Psychotic Symptoms Amongst Youth Endorsing Persistent Distressing Psychotic-Like Experiences," delivers comprehensive scientific...
- Federal Grant Award Summary The Center for Innovative Public Health Research received a $3.63M Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded September 10, 2025, with completion targeted for September 9, 2029. The grant funds a longitudinal research study examining the bidirectional association between adolescent social media exposure and mental health outcomes. The research team will recruit and follow...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Ohio State University a $652,145 Project Grant under the Mental Health Research Grants program (CFDA 93.242) on September 15, 2025, for research entitled "Longitudinal Modeling of Interpersonal Stress Induced Rumination to Understand Depression Risk in Adolescent Girls." The award supports a multimodal longitudinal study through July 31, 2030, designed to identify neural and behavioral mechanisms...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded McLean Hospital Corporation a $193,320 Project Grant effective February 18, 2026, through January 31, 2031, under the Mental Health Research Grants program (CFDA 93.242). This K23 mentored career development award supports research investigating online social networking (OSN) mechanisms related to suicidal thoughts and behaviors (STBS) in adolescents. The research deliverables include establishing objective,...
The National Institute of Mental Health (NIMH) awarded the University of Pittsburgh a Project Grant of $189,492 under the Mental Health Research Grants program (CFDA 93.242) on March 13, 2026, with a completion date of February 28, 2031. This K23 (Mentored Patient-Oriented Research Career Development Award) grant funds research testing an integrative neurobiological model of suicidal ideation (SI) in adolescents. The research examines the hypothesis that peripheral inflammatory markers (PIMs) such as IL-6, TNF-α, and CRP contribute to dysfunction in reward-related corticostriatal circuitry, which in turn contributes to adolescent SI. The study specifically investigates effort expenditure for reward as a behavioral correlate linked to SI and suicidal behavior (SB) in this vulnerable developmental population. The research deliverables include a longitudinal study following 90 adolescents with unipolar depressive disorders (enriched with those having a history of SI or SB) across four timepoints over twelve months. This project addresses a critical public health gap by clarifying biological mechanisms underlying adolescent suicide—the leading cause of non-accidental death in U.S. adolescents—with the ultimate goal of informing effective preventive treatments. By integrating inflammatory biomarkers, neuroimaging analysis of functional connectivity, and behavioral assessments of reward processing, this research advances understanding of the neurobiological pathways connecting immune activation to suicidal ideation during a critical developmental period when both reward circuitry and immune system maturation are occurring.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $189.5k | 3/19/26 |